Why the study?
Guidelines recommend early intensive statins for high-risk patients to prevent ACS-related events, but inconsistent statin utilization in current practice remains an issue.
Population
Patients with ACS across 49 eligible studies
Design
Systematic review of 38 cohort studies and cross-sectional studies
Authors
Loading...
Statin underutilization after ACS persists with post-discharge declines and disparities; challenges guideline implementation and extends research on barriers and equity.
Despite established guideline recommendations, statins remain underutilized for secondary prevention after ACS, with utilization rates declining during follow-up and disparities evident among female and elderly patients.
Dewi et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: